药物对比
Gliclazide vs Sotagliflozin
Gliclazide vs Sotagliflozin：磺脲类 vs SGLT1/2抑制剂治疗糖尿病和心力衰竭。比较作用机制、心血管获益、低血糖与酮症酸中毒风险。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when choosing oral therapy for type 2 diabetes patients, especially those with heart failure or at cardiovascular risk.
结论
Sotagliflozin may be preferred in heart failure due to proven benefits, but Gliclazide remains effective for glycemic control in suitable patients.
全部药物对比